OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer
Weisong Li, Kai Zhang, Wenjun Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Weisong Li, Kai Zhang, Wenjun Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Showing 4 citing articles:
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 7
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 7
Curcuminoids WM03 inhibits ovarian cancer cisplatin-resistant cells proliferation and reverses cisplatin resistance by targeting DYRK2
Minjie Zhang, Xiaoxi Wan, Mengna Shi, et al.
Phytomedicine (2025), pp. 156632-156632
Closed Access
Minjie Zhang, Xiaoxi Wan, Mengna Shi, et al.
Phytomedicine (2025), pp. 156632-156632
Closed Access
Synthesis, Antitumor Activities, and Apoptosis-Inducing Activities of Schiff’s Bases Incorporating Imidazolidine-2,4-dione Scaffold: Molecular Docking Studies and Enzymatic Inhibition Activities
Fhdah S. Alanazi, Hamad M. Alkahtani, Alaa A.‐M. Abdel‐Aziz, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 496-496
Open Access
Fhdah S. Alanazi, Hamad M. Alkahtani, Alaa A.‐M. Abdel‐Aziz, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 496-496
Open Access
Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors
Mater H. Mahnashi, Mohammed H. Nahari, Hassan H. Almasoudi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Mater H. Mahnashi, Mohammed H. Nahari, Hassan H. Almasoudi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Uncovering the regulatory roles of miR-4319 in tumour progression
Zhi Xiong Chong
Human Gene (2024) Vol. 41, pp. 201312-201312
Closed Access
Zhi Xiong Chong
Human Gene (2024) Vol. 41, pp. 201312-201312
Closed Access
